Back to Results
First PageMeta Content
Health / Anti-diabetic medication / Biguanide / Alpha-glucosidase inhibitor / Dipeptidyl peptidase-4 inhibitor / Hypoglycemia / Insulin / Diabetes / Endocrine system / Medicine


February 26, 2013 Press Release Mitsubishi Tanabe Pharma Corporation TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Application for Partial Change in Indications for Combination Therapy
Add to Reading List

Document Date: 2013-12-11 23:08:01

Open Document

File Size: 52,48 KB

Share Result on Facebook

City

Osaka / /

Company

Press Release Mitsubishi Tanabe Pharma Corporation / Mitsubishi Tanabe Pharma Corporation / Daiichi Sankyo / /

Country

Japan / /

Event

Business Partnership / /

IndustryTerm

treatment of diabetes / /

MedicalCondition

diabetes mellitus / diabetes / disease / /

Person

Michihiro Tsuchiya / /

/

Position

Director / CEO / President & Representative / /

Product

20mg / /

SocialTag